Home >> Healthcare >> Food & Beverage >>

Global Liposome Drug Delivery (Liposomes Drug Delivery) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published: Aug-2018 | Format: PDF | Global Info Research | Number of pages: 131 | Code: MRS - 355123

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. 

Scope of the Report:
This report focuses on the Liposome Drug Delivery (Liposomes Drug Delivery) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In consideration of the global economic and pharma industry, the growth rate of Liposomes Drug Delivery market will keep high in the next several years. The revenue market size expected to be 3.6 billion  in 2020 at a CAGR of 8.57%. 

North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.

Liposomes have been used in a broad range of pharmaceutical applications. Liposomes are showing particular promise as intracellular delivery systems for anti-sense molecules, ribosomes, proteins/peptides, and DNA. Liposomes with enhanced drug delivery to disease locations, by ability of long circulation residence times, are now achieving clinical acceptance. Also, liposomes promote targeting of particular diseased cells within the disease site. 

Finally, liposomal drugs exhibit reduced toxicities and retain enhanced efficacy compared with free complements. Based on the pharmaceutical applications and available products, we can say that liposomes have definitely established their position in modern delivery systems.

The worldwide market for Liposome Drug Delivery (Liposomes Drug Delivery) is expected to grow at a CAGR of roughly 10.0% over the next five years, will reach 4260 million US$ in 2023, from 2400 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
    Johnson & Johnson
    Gilead Sciences
    Pacira
    Sun Pharmaceutical
    Luye Pharma
    Sigma-Tau Group
    Fudan-Zhangjiang
    Teva Pharmaceutical
    CSPC
    Novartis
    Kingond Pharm
    Spectrum Pharmaceuticals
    Shanghai New Asia

Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Liposomal Doxorubicin
    Liposomal Amphoteracin B
    Liposomal Paclitaxel
    Other

Market Segment by Applications, can be divided into
    Fungal Infection Therapy
    Cancer & Tumor Therapy
    Other

There are 15 Chapters to deeply display the global Liposome Drug Delivery (Liposomes Drug Delivery) market.
Chapter 1, to describe Liposome Drug Delivery (Liposomes Drug Delivery) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Liposome Drug Delivery (Liposomes Drug Delivery), with sales, revenue, and price of Liposome Drug Delivery (Liposomes Drug Delivery), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Liposome Drug Delivery (Liposomes Drug Delivery), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Liposome Drug Delivery (Liposomes Drug Delivery) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Liposome Drug Delivery (Liposomes Drug Delivery) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents

1 Market Overview
    1.1 Liposome Drug Delivery (Liposomes Drug Delivery) Introduction
    1.2 Market Analysis by Type
        1.2.1 Liposomal Doxorubicin
        1.2.2 Liposomal Amphoteracin B
        1.2.3 Liposomal Paclitaxel
        1.2.4 Other
    1.3 Market Analysis by Applications
        1.3.1 Fungal Infection Therapy
        1.3.2 Cancer & Tumor Therapy
        1.3.3 Other
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2013-2023)
            1.4.1.2 Canada Market States and Outlook (2013-2023)
            1.4.1.3 Mexico Market States and Outlook (2013-2023)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2013-2023)
            1.4.2.2 France Market States and Outlook (2013-2023)
            1.4.2.3 UK Market States and Outlook (2013-2023)
            1.4.2.4 Russia Market States and Outlook (2013-2023)
            1.4.2.5 Italy Market States and Outlook (2013-2023)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2013-2023)
            1.4.3.2 Japan Market States and Outlook (2013-2023)
            1.4.3.3 Korea Market States and Outlook (2013-2023)
            1.4.3.4 India Market States and Outlook (2013-2023)
            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2013-2023)
            1.4.4.2 Egypt Market States and Outlook (2013-2023)
            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
            1.4.4.4 South Africa Market States and Outlook (2013-2023)
            1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Johnson & Johnson
        2.1.1 Business Overview
        2.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Gilead Sciences
        2.2.1 Business Overview
        2.2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Pacira
        2.3.1 Business Overview
        2.3.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Sun Pharmaceutical
        2.4.1 Business Overview
        2.4.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 Luye Pharma
        2.5.1 Business Overview
        2.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Sigma-Tau Group
        2.6.1 Business Overview
        2.6.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Fudan-Zhangjiang
        2.7.1 Business Overview
        2.7.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 Teva Pharmaceutical
        2.8.1 Business Overview
        2.8.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 CSPC
        2.9.1 Business Overview
        2.9.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 Novartis
        2.10.1 Business Overview
        2.10.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 Kingond Pharm
        2.11.1 Business Overview
        2.11.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 Kingond Pharm Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 Spectrum Pharmaceuticals
        2.12.1 Business Overview
        2.12.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.12.2.1 Product A
            2.12.2.2 Product B
        2.12.3 Spectrum Pharmaceuticals Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.13 Shanghai New Asia
        2.13.1 Business Overview
        2.13.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
            2.13.2.1 Product A
            2.13.2.2 Product B
        2.13.3 Shanghai New Asia Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
    3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Manufacturer (2016-2017)
    3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturer Market Share in 2017
        3.3.2 Top 6 Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturer Market Share in 2017
    3.4 Market Competition Trend
4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Analysis by Regions
    4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Regions
        4.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Regions (2013-2018)
        4.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Regions (2013-2018)
    4.2 North America Liposome Drug Delivery (Liposomes Drug Delivery)  Sales and Growth Rate (2013-2018)
    4.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery)  Sales and Growth Rate (2013-2018)
    4.4 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery)  Sales and Growth Rate (2013-2018)
    4.5 South America Liposome Drug Delivery (Liposomes Drug Delivery)  Sales and Growth Rate (2013-2018)
    4.6 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery)  Sales and Growth Rate (2013-2018)
5 North America Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
    5.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Countries
        5.1.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Countries (2013-2018)
        5.1.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Countries (2013-2018)
    5.2 United States Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    5.3 Canada Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    5.4 Mexico Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
6 Europe Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
    6.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Countries
        6.1.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Countries (2013-2018)
        6.1.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Countries (2013-2018)
    6.2 Germany Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    6.3 UK Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    6.4 France Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    6.5 Russia Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    6.6 Italy Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
7 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
    7.1 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Countries (2013-2018)
        7.1.2 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Countries (2013-2018)
    7.2 China Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    7.3 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    7.4 Korea Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    7.5 India Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    7.6 Southeast Asia Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
8 South America Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
    8.1 South America Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Countries
        8.1.1 South America Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Countries (2013-2018)
        8.1.2 South America Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Countries (2013-2018)
    8.2 Brazil Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    8.3 Argentina Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    8.4 Colombia Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
9 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
    9.1 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Countries (2013-2018)
        9.1.2 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Countries (2013-2018)
    9.2 Saudi Arabia Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    9.3 UAE Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    9.4 Egypt Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    9.5 Nigeria Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
    9.6 South Africa Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2013-2018)
10 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Segment by Type
    10.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Type (2013-2018)
        10.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Type (2013-2018)
        10.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Type (2013-2018)
    10.2 Liposomal Doxorubicin Sales Growth and Price
        10.2.1 Global Liposomal Doxorubicin Sales Growth (2013-2018)
        10.2.2 Global Liposomal Doxorubicin Price (2013-2018)
    10.3 Liposomal Amphoteracin B Sales Growth and Price
        10.3.1 Global Liposomal Amphoteracin B Sales Growth (2013-2018)
        10.3.2 Global Liposomal Amphoteracin B Price (2013-2018)
    10.4 Liposomal Paclitaxel Sales Growth and Price
        10.4.1 Global Liposomal Paclitaxel Sales Growth (2013-2018)
        10.4.2 Global Liposomal Paclitaxel Price (2013-2018)
    10.5 Other Sales Growth and Price
        10.5.1 Global Other Sales Growth (2013-2018)
        10.5.2 Global Other Price (2013-2018)
11 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Segment by Application
    11.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Application (2013-2018)
    11.2 Fungal Infection Therapy Sales Growth (2013-2018)
    11.3 Cancer & Tumor Therapy Sales Growth (2013-2018)
    11.4 Other Sales Growth (2013-2018)
12 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2018-2023)
    12.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Growth Rate (2018-2023)
    12.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by Regions (2018-2023)
        12.2.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2018-2023)
        12.2.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2018-2023)
        12.2.3 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2018-2023)
        12.2.4 South America Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2018-2023)
        12.2.5 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2018-2023)
    12.3 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by Type (2018-2023)
        12.3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Forecast by Type (2018-2023)
        12.3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Share Forecast by Type (2018-2023)
    12.4 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by Application (2018-2023)
        12.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Forecast by Application (2018-2023)
        12.4.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)3480 View Pricing